The efficiency of chronic disease care in sub-Saharan Africa / Pascal Geldsetzer, Katrina Ortblad and Till Bärnighausen
The number of people needing chronic disease care is projected to increase in sub-Saharan Africa as a result of expanding human immunodeficiency virus (HIV) treatment coverage, rising life expectancies, and lifestyle changes. Using nationally representative data of healthcare facilities, Di Giorgio et al. found that many HIV clinics in Kenya, Uganda, and Zambia appear to have considerable untapped capacity to provide care for additional patients. These findings highlight the potential for increasing the efficiency of clinical processes for chronic disease care at the facility level. Important questions for future research are how estimates of comparative technical efficiency across facilities change, when they are adjusted for quality of care and the composition of patients by care complexity. Looking ahead, substantial research investment will be needed to ensure that we do not forgo the opportunity to learn how efficiency changes, as chronic care is becoming increasingly differentiated by patient type and integrated across diseases and health systems functions.Please see related article: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0653-z..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 Aug 26 2016 |
---|---|
Erschienen: |
2016 Aug 26 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
BMC medicine - 14(2016) Artikel-Nummer 127, 4 Seiten |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Geldsetzer, Pascal [VerfasserIn] |
---|
Anmerkungen: |
Gesehen am 28.05.2020 |
---|
Umfang: |
4 |
---|
doi: |
10.1186/s12916-016-0675-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1698985282 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1698985282 | ||
003 | DE-627 | ||
005 | 20240406193205.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200528s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12916-016-0675-6 |2 doi | |
035 | |a (DE-627)1698985282 | ||
035 | |a (DE-599)KXP1698985282 | ||
035 | |a (OCoLC)1341326837 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Geldsetzer, Pascal |e verfasserin |0 (DE-588)1073833623 |0 (DE-627)829590501 |0 (DE-576)435307592 |4 aut | |
245 | 1 | 4 | |a The efficiency of chronic disease care in sub-Saharan Africa |c Pascal Geldsetzer, Katrina Ortblad and Till Bärnighausen |
264 | 1 | |c 2016 Aug 26 | |
300 | |a 4 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 28.05.2020 | ||
520 | |a The number of people needing chronic disease care is projected to increase in sub-Saharan Africa as a result of expanding human immunodeficiency virus (HIV) treatment coverage, rising life expectancies, and lifestyle changes. Using nationally representative data of healthcare facilities, Di Giorgio et al. found that many HIV clinics in Kenya, Uganda, and Zambia appear to have considerable untapped capacity to provide care for additional patients. These findings highlight the potential for increasing the efficiency of clinical processes for chronic disease care at the facility level. Important questions for future research are how estimates of comparative technical efficiency across facilities change, when they are adjusted for quality of care and the composition of patients by care complexity. Looking ahead, substantial research investment will be needed to ensure that we do not forgo the opportunity to learn how efficiency changes, as chronic care is becoming increasingly differentiated by patient type and integrated across diseases and health systems functions.Please see related article: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0653-z. | ||
650 | 4 | |a Africa South of the Sahara | |
650 | 4 | |a Antiretroviral therapy | |
650 | 4 | |a Chronic Disease | |
650 | 4 | |a Chronic diseases | |
650 | 4 | |a Differentiated care | |
650 | 4 | |a Efficiency | |
650 | 4 | |a HIV | |
650 | 4 | |a HIV Infections | |
650 | 4 | |a HIV-1 | |
650 | 4 | |a Humans | |
650 | 4 | |a Infection Control | |
650 | 4 | |a Integrated care | |
650 | 4 | |a Kenya | |
650 | 4 | |a Non-communicable diseases | |
650 | 4 | |a Program Evaluation | |
650 | 4 | |a Uganda | |
650 | 4 | |a Zambia | |
700 | 1 | |a Ortblad, Katrina |e verfasserin |0 (DE-588)113338367X |0 (DE-627)889239754 |0 (DE-576)489424236 |4 aut | |
700 | 1 | |a Bärnighausen, Till |d 1969- |e verfasserin |0 (DE-588)120262029 |0 (DE-627)080560512 |0 (DE-576)178470848 |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC medicine |d London : BioMed Central, 2003 |g 14(2016) Artikel-Nummer 127, 4 Seiten |h Online-Ressource |w (DE-627)377271225 |w (DE-600)2131669-7 |w (DE-576)121906655 |x 1741-7015 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2016 |g elocationid:127 |g extent:4 |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2031 | ||
912 | |a GBV_ILN_2038 | ||
912 | |a GBV_ILN_2044 | ||
912 | |a GBV_ILN_2048 | ||
912 | |a GBV_ILN_2050 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2056 | ||
912 | |a GBV_ILN_2057 | ||
912 | |a GBV_ILN_2061 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_2113 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2446 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 14 |j 2016 |i 127 |g 4 |y 14(2016) Artikel-Nummer 127, 4 Seiten | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 3673826166 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 28-05-20 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2016 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_3 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_4 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1504682815 |a Bärnighausen, Till | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1493871218 |a Institut für Public Health (IPH) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_3 |